16th-18th September 2008 * President Wilson Hotel, Geneva * Call the Bookings Hotline on +44 (0)20 7368 9465

EVENT DETAILS
GET INVOLVED
DELEGATE INFORMATION
OUR PARTNERS
WBR


SUBMIT YOUR EMAIL
to receive special offers
and event updates:



 


Sponsors

 

Sai Advantium Pharma (http://www.saiadvantium.com) is chemistry services provider, with facilities in Hyderabad and Pune, India, providing early discovery and development support to Pharma and Biotech worldwide. We offer:

  • Medicinal Chemistry
  • Process Development and Scale-Up
  • cGMP Manufacturing
  • PK/ADME, Library Design, Formulation Development

Our expertise allows us to offer chemistry R&D throughout the drug discovery and development process, with the capability to support a full drug development project (from initial lead identification, optimisation and initial scale-up, to process development and GMP supply) or individual activities throughout the R&D process. Sai Advantium has no internal discovery programs, and is committed to bringing value to client drug pipelines by providing cost-effective R&D support through a uniquely experienced senior management team and dedicated project teams. With a focus on “No Surprises” Sai Advantium is committed to clear communication and effective project management, delivering clients’ aims as quickly and efficiently as possible.
Merck Serono is the division for innovative prescription pharmaceuticals of Merck, a global pharmaceutical and chemical group. Headquartered in Geneva, Switzerland, Merck Serono discovers, develops, manufactures and markets innovative small molecules and biopharmaceuticals to help patients with unmet medical needs. Its North American business operates in the United States and Canada as EMD Serono. Merck Serono has leading brands serving patients with cancer (Erbitux®), multiple sclerosis (Rebif®), infertility (Gonal-f®), endocrine and cardiometabolic disorders (Glucophage®, Concor®, Saizen®, Serostim®), as well as psoriasis (Raptiva®). With an annual R&D investment of around e1bn, Merck Serono is committed to growing its business in specialist-focused therapeutic areas including neurodegenerative diseases, oncology, fertility and endocrinology, as well as new areas potentially arising out of research and development in autoimmune and inflammatory diseases. For more information, please visit www.merckserono.net or www.merck.de

Accelera is a premium tier Contract Research Organization (CRO), working and collaborating with pharmaceutical and biotechnology companies around the world. Accelera helps you “pick the best” among your drug candidates and execute optimized development plans. Services include:

  • Dedicated biologics/biomarker capabilities;
  • ADME/PK studies in multiple species, including Nonhuman Primates for biologics;
  • Flow Cytometry, qELISA, Luminex platforms;
  • Preclinical and clinical bioanalysis and PK, including assay development and validation, PK/PD, and population PK data analysis;
  • Toxicology/safety pharmacology packages;
  • High-throughput preclinical profiling;
  • Special expertise in the design and execution of Oncology focused programs.

Accelera is uniquely able to provide mainstream pharma capabilities and experience in response to your preclinical development needs, adding value to your products, reducing late attrition rates and improving cycle times. With Accelera, experience results.